Back to Search Start Over

Antioxidant and Antiapoptotic Properties of n-Butanol Fraction the Acanthopanax senticosus Extracts in H 2 O 2 -RAW264.7 Cells and CCl 4 -Induced Liver Injury in Mice.

Authors :
Su J
Fu X
Liu R
Zhang X
Xue J
Li Y
Zhang R
Li X
Wang X
Wang X
Ding Y
Chu X
Source :
Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2023 Feb 23; Vol. 2023, pp. 9190198. Date of Electronic Publication: 2023 Feb 23 (Print Publication: 2023).
Publication Year :
2023

Abstract

The Acanthopanax senticosus has been shown to have a wide range of pharmacological activities, which are associated with health benefits, such as antioxidant, anti-inflammatory, and antiapoptotic properties. A previous study has shown that the n-butanol fraction of A . senticosus extract had the strongest antioxidant effect in vitro. This study aimed to investigate the effects that the n-butanol fraction of A . senticosus extract could relieve oxidative stress damage through antioxidant and antiapoptotic in the H <subscript>2</subscript> O <subscript>2</subscript> -stimulated RAW264.7 macrophages and the CCl <subscript>4</subscript> -induced liver injury. The result showed that the n-butanol fraction extract could relieve damage by increasing the intracellular antioxidant enzymes (SOD) level, decreasing intracellular ROS and MDA levels, and regulating antioxidant and antiapoptotic-related gene expression levels. The morphological observation of HE, TUNE, and immunohistochemistry staining of liver tissue verified that the n-butanol fraction extract is though anti-oxidative and antiapoptotic to alleviate cellular oxidative damage. The RT-PCR assay showed that the Keap1-Nrf2-ARE and the Bax/Bcl-2 signaling pathway were related to the molecular mechanism of action. The experimental results show that Acanthopanax senticosus extract has a good effect in treating liver injury and enhancing the antioxidant capacity of the body.<br />Competing Interests: The authors declare that they have no conflicts of interest regarding the publication of this paper.<br /> (Copyright © 2023 Jianqing Su et al.)

Details

Language :
English
ISSN :
1741-427X
Volume :
2023
Database :
MEDLINE
Journal :
Evidence-based complementary and alternative medicine : eCAM
Publication Type :
Academic Journal
Accession number :
36874619
Full Text :
https://doi.org/10.1155/2023/9190198